A AB BS ST TR RA AC CT T O Ob bj je ec ct ti iv ve e: : To compare the serum level of total antioxidant status (TAS), malondialdehyde (MDA) and erythrocyte superoxide dismutase (SOD) levels in Hashimoto thyroiditis patients treated with levothyroxine and healthy control subjects and to assess possible correlations of these parameters with biochemical parameters such as glucose and lipid profile. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : SOD, TAS, MDA, fasting glucose, lipid profile, thyroid hormones and body mass index (BMI) were measured in 30 Hashimoto thyroiditis patients treated with levothyroxine and 30 healthy control subjects. R Re es su ul lt ts s: : Body Mass Index was increased in Hashimoto thyroiditis patients compared to control subjects. The biochemical parameters such as glucose, triglycerides, total cholesterol and low-density lipoprotein cholesterol (LDL-C) were higher and high-density lipoprotein cholesterol (HDL-C) was lower in the patient group than in control patients. TAS and MDA levels were significantly higher and erythrocyte SOD levels were lower in the patient group compared to the control group. C Co on nc cl lu us si io on n: : Our study showed that lipid peroxidation was increased in hypothyroid patients compared to healthy controls, even though they were treated with levothyroxine. Erytrocyte SOD levels were lower and TAS was higher in the patient group compared to the control group. Thyroiditis patients treated with levothyroxine had normal thyroid homone ranges but treatment did not seem to improve dyslipidemia and oxidative stres. In conclusion, although the hypothyroid patients had normal thyroid hormone levels due to levothyroxine treatment, oxidative stress parameters seemed to contiue to increase. Thus, we suggest that antioxidant treatment may be continued even after the achievement of euthyroidism.K Ke ey y W Wo or rd ds s: : Malondialdehyde; superoxide dismutase; Hashimoto disease; body mass index Ö ÖZ ZE ET T A Am ma aç ç: : Serum total antioksidan kapasitesi (TAK), malondialdehit (MDA) ve eritrosit süperoksit dismutaz (SOD) düzeylerinin, levotiroksin tedavisi gören Hashimoto tiroiditi hastaları ile sağlıklı kontroller arasında karşılaştırılması ve bu parametrelerin glikoz ve lipit profili gibi biyokimyasal parametreler ile olası ilişkilerinin değerlendirilmesi amaçlanmıştır. G Ge er re eç ç v ve e Y Yö ön nt te em ml le er r: : Bu çalışmaya, levotiroksin tedavisi gören 30 Hashimoto tiroiditi hastası ve 30 sağlıklı birey dâhil edilmiştir. Bütün bireylerde SOD, TAK, MDA, açlık glikozu, lipit profili, tiroit hormonları ölçümleri yapılmış ve beden kitle indeksi (BKİ) hesaplanmıştır. B Bu ul lg gu ul la ar r: : Levotiroksin tedavisi gören Hashimoto tiroiditi hastalarında BKİ'nin ve glikoz, trigliserit, total kolesterol ve düşük yoğunluklu lipoprotein kolesterol (LDL-C) gibi biyokimyasal parametrelerin düzeyinin artmış olduğu saptanmıştır. Yüksek yoğunluklu lipoprotein kolesterol (HDL-C) düzeyinin ise hasta grubunda azalmış olduğu belirlenmiştir. TAK ve MDA dü...